Evidence map›Paper›PMID 26775291›Full record

ArticleParasites & vectors2016

Assessment of the FasciMol-ELISA in the detection of the trematode Fasciola hepatica in field-collected Galba cubensis: a novel tool for the malacological survey of fasciolosis transmission.

Annia Alba, Antonio A Vázquez, Jorge Sánchez, Jorge Fraga, Hilda Hernández, Elizabeth Martínez, Ricardo Marcet, Mabel Figueredo, Jorge Sarracent

Abstract read
In one paragraph

Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Immunological Resistance ofFrontiers in immunology · 2022
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Annia AlbaLaboratory of Monoclonal Antibodies and Biological Models, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. annia@ipk.sld.cu.
Antonio A VázquezLaboratory of Malacology, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. antonivp@ipk.sld.cu.
Jorge SánchezLaboratory of Malacology, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. jsnoda@ipk.sld.cu.
Jorge FragaLaboratory of Molecular Parasitology, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. fraga@ipk.sld.cu.
Hilda HernándezLaboratory of Monoclonal Antibodies and Biological Models, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. Hilda@ipk.sld.cu.
Elizabeth MartínezLaboratory of Malacology, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. emartinez@ipk.sld.cu.
Ricardo MarcetLaboratory of Monoclonal Antibodies and Biological Models, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. marcet@ipk.sld.cu.
Mabel FigueredoLaboratory of Monoclonal Antibodies and Biological Models, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. MabelF@ipk.sld.cu.
Jorge SarracentLaboratory of Monoclonal Antibodies and Biological Models, Parasitology Division, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. sarracent@ipk.sld.cu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFasciolosis is one of the food-borne neglected trematodioses that has reemerged as a human disease while its effects on domestic animal health remains of significant economic consideration. Being snail-borne disease, the accurate and time-saving epidemiological surveillance of the transmission foci where infected lymnaeid snails occur could be essential to effectively focus or redirect control strategies. For this purpose, the first monoclonal antibody-based immunoenzymatic assay to detect Fasciola hepatica-infected snails (FasciMol-ELISA) was recently developed and showed a high sensitivity and specificity when tested in an experimental F. hepatica - Galba cubensis system.

methodsHere, we surveyed populations of G. cubensis occurring in western Cuba for the assessment of the FasciMol-ELISA in determining natural F. hepatica infection in this intermediate host. A multiplex PCR, previously developed to detect F. hepatica in G. cubensis, was used for sample classification. Snail dissection method was also employed as screening technique. A Χ(2) test and a Kappa index were calculated to evaluate the positivity and the level of agreement between the FasciMol-ELISA and the snail dissection methods with the multiplex PCR, respectively.

resultsGalba cubensis was found in nine out of 12 sampled localities of which four were positive for F. hepatica infection as detected by both immunoenzymatic and PCR-based assays. The overall prevalence was higher than the natural infection rates previously reported for Cuban G. cubensis (range from 4.1 to 7.42% depending on the screening method). No significant differences were found between FasciMol-ELISA and multiplex PCR when determining parasite positivity (Χ(2) = 6.283; P = 0.0981) whereas an excellent agreement was also noted (Kappa = 0.8224).

conclusionsOur results demonstrate the importance of malacological surveys in assessing parasite transmission risk and constitute an alert on the need of accurate measures to control fasciolosis in western Cuba. The sensitivity and specificity of the FasciMol-ELISA as well as its time-saving capacity and the easy of performing the determination of a large number of samples, point at this assay as a novel tool suitable for large-scale monitoring of natural snails populations. To our knowledge, this is the first study that explores natural infection by F. hepatica in field-occurring lymnaeid snails using an immunoenzymatic assay.

Indexed as

AnimalsAntibodies, MonoclonalCubaEnzyme-Linked Immunosorbent AssayFasciola hepaticaFascioliasisHumansImmunoenzyme TechniquesLivestockLymnaeaSensitivity and SpecificitySpecies SpecificitySurveys and QuestionnairesAntibodies, Monoclonal

Identifiers

PMID26775291
PMCPMC4715296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.